Wellnex (ASX:WNX) - CEO, George Karafotias
CEO, George Karafotias
Source: Wellnex
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Wellnex Life (WNX) has grown revenue by 18.5 per cent to $8.84 million during the first half of the 2022 financial year
  • According to the unaudited results, the jump in revenue was accompanied by a 14.1 per cent growth in margins for the six-month period to 33.1 per cent
  • The increase in revenue comes despite the impact of lockdowns and global logistics disruptions impacting sales
  • Wellnex has already received $1.6 million in purchase orders to be invoiced in 2H, and remains on track to achieve or surpass its target of $21 million in revenue for FY22
  • Shares in WNX were trading up 7.14 per cent at 10.5 cents each

Wellnex Life (WNX) has grown revenue by 18.5 per cent to $8.84 million during the first half of the 2022 financial year.

According to the unaudited results, the jump in revenue was accompanied by a 14.1 per cent growth in margins for the six-month period to 33.1 per cent

WNX said the increase in revenue comes despite the impact of lockdowns across Australia’s east coast due to COVID-19.

It also dealt with global logistics disruptions impacting sales, and the company said it would counter the same issues from re-occurring in the second half by securing additional stock.

Wellnex has already received $1.6 million in purchase orders to be invoiced in 2H, and remains on track to achieve or surpass its target of $21 million in revenue for FY22.

The growth will be supported by several launches, including supermarket giants Coles (COL) and Woolworths (WOW) stocking WNX’s Wakey Wakey and The Iron Company brand.

Additionally, further growth is expected in the Wagner Liquigesic brand, while the Pharmacy Own brand will also launch in 2022.

“It has been a transformational 6 months for Wellnex with the company experiencing significant growth in revenue despite many headwinds,” CEO George Karafotias said.

“This is testament to the strength of the business which will see continued growth in sales and margins in the fast-growing health and wellness market.”

Shares in WNX were trading up 7.14 per cent at 10.5 cents each at 1:00 pm AEDT.

WNX by the numbers
More From The Market Herald

" Chalice Mining (ASX:CHN) maintains strong focus on top-tier Gonneville deposit

ASX 200-listed Chalice Mining (ASX:CHN) has had a rocky day on the ASX following the release…
Credit Clear (ASX:CCR) - CEO, David Hentschke

" Credit Clear (ASX:CRR) to boost revenue by $2m with new clients

Receivables management solution provider Credit Clear (CCR) has signed two new clients which are set to boost revenue by between $1.6 million and...

" PointsBet (ASX:PBH) losses extend to $51.8m

PointsBet (ASX:PBH) has reported $51.8 million in cash outflows for its quarterly update as the company…
Imugene (ASX:IMU) - CEO, Leslie Chong

" Imugene (ASX:IMU) signs clinical trial agreement with Roche for lung cancer

Imugene (ASX:IMU) signs a clinical trial supply agreement with Roche to evaluate the combination of treatments…